nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—type 2 diabetes mellitus	0.303	1	CbGaD
Pyridostigmine—BCHE—Ramipril—type 2 diabetes mellitus	0.148	0.339	CbGbCtD
Pyridostigmine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.044	0.101	CbGbCtD
Pyridostigmine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0392	0.0898	CbGbCtD
Pyridostigmine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0358	0.0821	CbGbCtD
Pyridostigmine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0313	0.0718	CbGbCtD
Pyridostigmine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0283	0.0649	CbGbCtD
Pyridostigmine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0215	0.0492	CbGbCtD
Pyridostigmine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0206	0.0472	CbGbCtD
Pyridostigmine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0206	0.0472	CbGbCtD
Pyridostigmine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0195	0.0446	CbGbCtD
Pyridostigmine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0145	0.0332	CbGbCtD
Pyridostigmine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0133	0.0304	CbGbCtD
Pyridostigmine—Rivastigmine—CYP3A4—type 2 diabetes mellitus	0.000671	1	CrCbGaD
Pyridostigmine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000291	0.00151	CcSEcCtD
Pyridostigmine—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.00029	0.0015	CcSEcCtD
Pyridostigmine—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.00029	0.0015	CcSEcCtD
Pyridostigmine—Myalgia—Glyburide—type 2 diabetes mellitus	0.000289	0.00149	CcSEcCtD
Pyridostigmine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000286	0.00148	CcSEcCtD
Pyridostigmine—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000284	0.00147	CcSEcCtD
Pyridostigmine—Alopecia—Valsartan—type 2 diabetes mellitus	0.000284	0.00147	CcSEcCtD
Pyridostigmine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000284	0.00147	CcSEcCtD
Pyridostigmine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000283	0.00146	CcSEcCtD
Pyridostigmine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000281	0.00146	CcSEcCtD
Pyridostigmine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000281	0.00145	CcSEcCtD
Pyridostigmine—Alopecia—Orlistat—type 2 diabetes mellitus	0.000281	0.00145	CcSEcCtD
Pyridostigmine—Agitation—Gliclazide—type 2 diabetes mellitus	0.00028	0.00145	CcSEcCtD
Pyridostigmine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000279	0.00144	CcSEcCtD
Pyridostigmine—Asthma—Ramipril—type 2 diabetes mellitus	0.000278	0.00144	CcSEcCtD
Pyridostigmine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000276	0.00143	CcSEcCtD
Pyridostigmine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000276	0.00143	CcSEcCtD
Pyridostigmine—Flatulence—Valsartan—type 2 diabetes mellitus	0.000276	0.00143	CcSEcCtD
Pyridostigmine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000276	0.00143	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000275	0.00142	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000274	0.00142	CcSEcCtD
Pyridostigmine—Rash—Repaglinide—type 2 diabetes mellitus	0.000274	0.00142	CcSEcCtD
Pyridostigmine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000274	0.00142	CcSEcCtD
Pyridostigmine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000274	0.00142	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000273	0.00142	CcSEcCtD
Pyridostigmine—Epistaxis—Losartan—type 2 diabetes mellitus	0.000273	0.00141	CcSEcCtD
Pyridostigmine—Flatulence—Orlistat—type 2 diabetes mellitus	0.000272	0.00141	CcSEcCtD
Pyridostigmine—Headache—Repaglinide—type 2 diabetes mellitus	0.000272	0.00141	CcSEcCtD
Pyridostigmine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00141	CcSEcCtD
Pyridostigmine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000271	0.0014	CcSEcCtD
Pyridostigmine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00139	CcSEcCtD
Pyridostigmine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000269	0.00139	CcSEcCtD
Pyridostigmine—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000268	0.00139	CcSEcCtD
Pyridostigmine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000268	0.00139	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000267	0.00138	CcSEcCtD
Pyridostigmine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000267	0.00138	CcSEcCtD
Pyridostigmine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000266	0.00138	CcSEcCtD
Pyridostigmine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000266	0.00138	CcSEcCtD
Pyridostigmine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000265	0.00137	CcSEcCtD
Pyridostigmine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000265	0.00137	CcSEcCtD
Pyridostigmine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000264	0.00137	CcSEcCtD
Pyridostigmine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000264	0.00137	CcSEcCtD
Pyridostigmine—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000259	0.00134	CcSEcCtD
Pyridostigmine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000259	0.00134	CcSEcCtD
Pyridostigmine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000259	0.00134	CcSEcCtD
Pyridostigmine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000259	0.00134	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000259	0.00134	CcSEcCtD
Pyridostigmine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000258	0.00134	CcSEcCtD
Pyridostigmine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000258	0.00134	CcSEcCtD
Pyridostigmine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000257	0.00133	CcSEcCtD
Pyridostigmine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000254	0.00131	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000252	0.00131	CcSEcCtD
Pyridostigmine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000251	0.0013	CcSEcCtD
Pyridostigmine—Flatulence—Metformin—type 2 diabetes mellitus	0.000251	0.0013	CcSEcCtD
Pyridostigmine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000251	0.0013	CcSEcCtD
Pyridostigmine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000249	0.00129	CcSEcCtD
Pyridostigmine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000248	0.00129	CcSEcCtD
Pyridostigmine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000248	0.00129	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000248	0.00128	CcSEcCtD
Pyridostigmine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000247	0.00128	CcSEcCtD
Pyridostigmine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000247	0.00128	CcSEcCtD
Pyridostigmine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000246	0.00128	CcSEcCtD
Pyridostigmine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000246	0.00127	CcSEcCtD
Pyridostigmine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000246	0.00127	CcSEcCtD
Pyridostigmine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000245	0.00127	CcSEcCtD
Pyridostigmine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000244	0.00126	CcSEcCtD
Pyridostigmine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000241	0.00125	CcSEcCtD
Pyridostigmine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00124	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00024	0.00124	CcSEcCtD
Pyridostigmine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00024	0.00124	CcSEcCtD
Pyridostigmine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000239	0.00124	CcSEcCtD
Pyridostigmine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000239	0.00124	CcSEcCtD
Pyridostigmine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000238	0.00123	CcSEcCtD
Pyridostigmine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000237	0.00123	CcSEcCtD
Pyridostigmine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000236	0.00122	CcSEcCtD
Pyridostigmine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000235	0.00122	CcSEcCtD
Pyridostigmine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000234	0.00121	CcSEcCtD
Pyridostigmine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000232	0.0012	CcSEcCtD
Pyridostigmine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000231	0.0012	CcSEcCtD
Pyridostigmine—Alopecia—Losartan—type 2 diabetes mellitus	0.00023	0.00119	CcSEcCtD
Pyridostigmine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00023	0.00119	CcSEcCtD
Pyridostigmine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00118	CcSEcCtD
Pyridostigmine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000229	0.00118	CcSEcCtD
Pyridostigmine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000228	0.00118	CcSEcCtD
Pyridostigmine—Rash—Glipizide—type 2 diabetes mellitus	0.000227	0.00117	CcSEcCtD
Pyridostigmine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000226	0.00117	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000226	0.00117	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000226	0.00117	CcSEcCtD
Pyridostigmine—Headache—Glipizide—type 2 diabetes mellitus	0.000225	0.00117	CcSEcCtD
Pyridostigmine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000224	0.00116	CcSEcCtD
Pyridostigmine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000223	0.00116	CcSEcCtD
Pyridostigmine—Flatulence—Losartan—type 2 diabetes mellitus	0.000223	0.00115	CcSEcCtD
Pyridostigmine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000221	0.00114	CcSEcCtD
Pyridostigmine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000221	0.00114	CcSEcCtD
Pyridostigmine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00022	0.00114	CcSEcCtD
Pyridostigmine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000219	0.00113	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000218	0.00113	CcSEcCtD
Pyridostigmine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000217	0.00113	CcSEcCtD
Pyridostigmine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000217	0.00112	CcSEcCtD
Pyridostigmine—Myalgia—Metformin—type 2 diabetes mellitus	0.000217	0.00112	CcSEcCtD
Pyridostigmine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000216	0.00112	CcSEcCtD
Pyridostigmine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000216	0.00112	CcSEcCtD
Pyridostigmine—Nausea—Glipizide—type 2 diabetes mellitus	0.000214	0.00111	CcSEcCtD
Pyridostigmine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Pyridostigmine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Pyridostigmine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Pyridostigmine—Rash—Glimepiride—type 2 diabetes mellitus	0.000212	0.0011	CcSEcCtD
Pyridostigmine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000211	0.00109	CcSEcCtD
Pyridostigmine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000211	0.00109	CcSEcCtD
Pyridostigmine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00109	CcSEcCtD
Pyridostigmine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00109	CcSEcCtD
Pyridostigmine—Headache—Glimepiride—type 2 diabetes mellitus	0.00021	0.00109	CcSEcCtD
Pyridostigmine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00108	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000208	0.00108	CcSEcCtD
Pyridostigmine—Agitation—Losartan—type 2 diabetes mellitus	0.000208	0.00108	CcSEcCtD
Pyridostigmine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00107	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000206	0.00106	CcSEcCtD
Pyridostigmine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000205	0.00106	CcSEcCtD
Pyridostigmine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000205	0.00106	CcSEcCtD
Pyridostigmine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000205	0.00106	CcSEcCtD
Pyridostigmine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000204	0.00106	CcSEcCtD
Pyridostigmine—Vertigo—Losartan—type 2 diabetes mellitus	0.000203	0.00105	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000203	0.00105	CcSEcCtD
Pyridostigmine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000203	0.00105	CcSEcCtD
Pyridostigmine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000203	0.00105	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Pyridostigmine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Pyridostigmine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Pyridostigmine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Pyridostigmine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Pyridostigmine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000197	0.00102	CcSEcCtD
Pyridostigmine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000197	0.00102	CcSEcCtD
Pyridostigmine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000196	0.00102	CcSEcCtD
Pyridostigmine—Hypotension—Metformin—type 2 diabetes mellitus	0.000194	0.00101	CcSEcCtD
Pyridostigmine—Myalgia—Losartan—type 2 diabetes mellitus	0.000193	0.000997	CcSEcCtD
Pyridostigmine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000192	0.000996	CcSEcCtD
Pyridostigmine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000191	0.000988	CcSEcCtD
Pyridostigmine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000191	0.000987	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00019	0.000982	CcSEcCtD
Pyridostigmine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00019	0.000982	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000189	0.000981	CcSEcCtD
Pyridostigmine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000189	0.00098	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000187	0.000966	CcSEcCtD
Pyridostigmine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000187	0.000966	CcSEcCtD
Pyridostigmine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000186	0.000965	CcSEcCtD
Pyridostigmine—Confusional state—Losartan—type 2 diabetes mellitus	0.000186	0.000964	CcSEcCtD
Pyridostigmine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000186	0.000962	CcSEcCtD
Pyridostigmine—Somnolence—Metformin—type 2 diabetes mellitus	0.000185	0.000957	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000184	0.000955	CcSEcCtD
Pyridostigmine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000183	0.000949	CcSEcCtD
Pyridostigmine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000183	0.000948	CcSEcCtD
Pyridostigmine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000181	0.000939	CcSEcCtD
Pyridostigmine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00018	0.000934	CcSEcCtD
Pyridostigmine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00018	0.000931	CcSEcCtD
Pyridostigmine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000179	0.000928	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000179	0.000925	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000178	0.000924	CcSEcCtD
Pyridostigmine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000178	0.000923	CcSEcCtD
Pyridostigmine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000178	0.000923	CcSEcCtD
Pyridostigmine—Agitation—Ramipril—type 2 diabetes mellitus	0.000178	0.000923	CcSEcCtD
Pyridostigmine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000176	0.000912	CcSEcCtD
Pyridostigmine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000176	0.000911	CcSEcCtD
Pyridostigmine—Rash—Glyburide—type 2 diabetes mellitus	0.000174	0.000903	CcSEcCtD
Pyridostigmine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000174	0.000903	CcSEcCtD
Pyridostigmine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000174	0.000902	CcSEcCtD
Pyridostigmine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000174	0.000902	CcSEcCtD
Pyridostigmine—Headache—Glyburide—type 2 diabetes mellitus	0.000173	0.000897	CcSEcCtD
Pyridostigmine—Hypotension—Losartan—type 2 diabetes mellitus	0.000173	0.000893	CcSEcCtD
Pyridostigmine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000171	0.000887	CcSEcCtD
Pyridostigmine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00017	0.000883	CcSEcCtD
Pyridostigmine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00017	0.00088	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00017	0.00088	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000168	0.000871	CcSEcCtD
Pyridostigmine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000168	0.000871	CcSEcCtD
Pyridostigmine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000168	0.00087	CcSEcCtD
Pyridostigmine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000166	0.00086	CcSEcCtD
Pyridostigmine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000166	0.000858	CcSEcCtD
Pyridostigmine—Urticaria—Metformin—type 2 diabetes mellitus	0.000165	0.000855	CcSEcCtD
Pyridostigmine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000165	0.000855	CcSEcCtD
Pyridostigmine—Nausea—Glyburide—type 2 diabetes mellitus	0.000164	0.000851	CcSEcCtD
Pyridostigmine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000164	0.000851	CcSEcCtD
Pyridostigmine—Somnolence—Losartan—type 2 diabetes mellitus	0.000164	0.00085	CcSEcCtD
Pyridostigmine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000164	0.000848	CcSEcCtD
Pyridostigmine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000162	0.000838	CcSEcCtD
Pyridostigmine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000162	0.000837	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00016	0.000831	CcSEcCtD
Pyridostigmine—Confusional state—Ramipril—type 2 diabetes mellitus	0.00016	0.000826	CcSEcCtD
Pyridostigmine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000158	0.000818	CcSEcCtD
Pyridostigmine—Rash—Gliclazide—type 2 diabetes mellitus	0.000157	0.000811	CcSEcCtD
Pyridostigmine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000157	0.00081	CcSEcCtD
Pyridostigmine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000156	0.000809	CcSEcCtD
Pyridostigmine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000156	0.000807	CcSEcCtD
Pyridostigmine—Headache—Gliclazide—type 2 diabetes mellitus	0.000156	0.000806	CcSEcCtD
Pyridostigmine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000155	0.000803	CcSEcCtD
Pyridostigmine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000154	0.000799	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000153	0.000792	CcSEcCtD
Pyridostigmine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000152	0.000788	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000151	0.000782	CcSEcCtD
Pyridostigmine—Asthenia—Metformin—type 2 diabetes mellitus	0.000149	0.000772	CcSEcCtD
Pyridostigmine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000148	0.000766	CcSEcCtD
Pyridostigmine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000148	0.000764	CcSEcCtD
Pyridostigmine—Urticaria—Losartan—type 2 diabetes mellitus	0.000147	0.000759	CcSEcCtD
Pyridostigmine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000146	0.000756	CcSEcCtD
Pyridostigmine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000145	0.000751	CcSEcCtD
Pyridostigmine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000145	0.000748	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000144	0.000747	CcSEcCtD
Pyridostigmine—Rash—Valsartan—type 2 diabetes mellitus	0.000144	0.000745	CcSEcCtD
Pyridostigmine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000144	0.000744	CcSEcCtD
Pyridostigmine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000143	0.000743	CcSEcCtD
Pyridostigmine—Headache—Valsartan—type 2 diabetes mellitus	0.000143	0.00074	CcSEcCtD
Pyridostigmine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000142	0.000736	CcSEcCtD
Pyridostigmine—Rash—Orlistat—type 2 diabetes mellitus	0.000142	0.000736	CcSEcCtD
Pyridostigmine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000142	0.000736	CcSEcCtD
Pyridostigmine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000142	0.000736	CcSEcCtD
Pyridostigmine—Headache—Orlistat—type 2 diabetes mellitus	0.000141	0.000732	CcSEcCtD
Pyridostigmine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000141	0.000729	CcSEcCtD
Pyridostigmine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000141	0.000729	CcSEcCtD
Pyridostigmine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000136	0.000704	CcSEcCtD
Pyridostigmine—Nausea—Valsartan—type 2 diabetes mellitus	0.000136	0.000702	CcSEcCtD
Pyridostigmine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000134	0.000695	CcSEcCtD
Pyridostigmine—Nausea—Orlistat—type 2 diabetes mellitus	0.000134	0.000694	CcSEcCtD
Pyridostigmine—Asthenia—Losartan—type 2 diabetes mellitus	0.000132	0.000686	CcSEcCtD
Pyridostigmine—Vomiting—Metformin—type 2 diabetes mellitus	0.000132	0.000684	CcSEcCtD
Pyridostigmine—Rash—Metformin—type 2 diabetes mellitus	0.000131	0.000679	CcSEcCtD
Pyridostigmine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000131	0.000678	CcSEcCtD
Pyridostigmine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00013	0.000675	CcSEcCtD
Pyridostigmine—Headache—Metformin—type 2 diabetes mellitus	0.00013	0.000674	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000129	0.00067	CcSEcCtD
Pyridostigmine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000126	0.000654	CcSEcCtD
Pyridostigmine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000126	0.000651	CcSEcCtD
Pyridostigmine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000125	0.000648	CcSEcCtD
Pyridostigmine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000125	0.000646	CcSEcCtD
Pyridostigmine—Rash—Irbesartan—type 2 diabetes mellitus	0.000124	0.00064	CcSEcCtD
Pyridostigmine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000124	0.00064	CcSEcCtD
Pyridostigmine—Nausea—Metformin—type 2 diabetes mellitus	0.000123	0.000639	CcSEcCtD
Pyridostigmine—Headache—Irbesartan—type 2 diabetes mellitus	0.000123	0.000636	CcSEcCtD
Pyridostigmine—Vomiting—Losartan—type 2 diabetes mellitus	0.000117	0.000608	CcSEcCtD
Pyridostigmine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000117	0.000604	CcSEcCtD
Pyridostigmine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000117	0.000603	CcSEcCtD
Pyridostigmine—Rash—Losartan—type 2 diabetes mellitus	0.000116	0.000603	CcSEcCtD
Pyridostigmine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000116	0.000602	CcSEcCtD
Pyridostigmine—Headache—Losartan—type 2 diabetes mellitus	0.000116	0.000599	CcSEcCtD
Pyridostigmine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000114	0.000588	CcSEcCtD
Pyridostigmine—Nausea—Losartan—type 2 diabetes mellitus	0.00011	0.000568	CcSEcCtD
Pyridostigmine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000108	0.000561	CcSEcCtD
Pyridostigmine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000101	0.000521	CcSEcCtD
Pyridostigmine—Rash—Ramipril—type 2 diabetes mellitus	9.98e-05	0.000517	CcSEcCtD
Pyridostigmine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000516	CcSEcCtD
Pyridostigmine—Headache—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000513	CcSEcCtD
Pyridostigmine—Nausea—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000487	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	4.54e-05	0.000682	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ABCC8—type 2 diabetes mellitus	4.53e-05	0.00068	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CBS—type 2 diabetes mellitus	4.53e-05	0.00068	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PCK1—type 2 diabetes mellitus	4.44e-05	0.000666	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.37e-05	0.000656	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	4.36e-05	0.000655	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC5A2—type 2 diabetes mellitus	4.36e-05	0.000654	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—COX2—type 2 diabetes mellitus	4.36e-05	0.000654	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.34e-05	0.000652	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	4.29e-05	0.000644	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NCOA6—type 2 diabetes mellitus	4.28e-05	0.000643	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.28e-05	0.000643	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	4.26e-05	0.00064	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.26e-05	0.000639	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—UCP2—type 2 diabetes mellitus	4.21e-05	0.000632	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—UCP3—type 2 diabetes mellitus	4.21e-05	0.000632	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HSD11B1—type 2 diabetes mellitus	4.21e-05	0.000632	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HK1—type 2 diabetes mellitus	4.15e-05	0.000624	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	4.15e-05	0.000623	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	4.14e-05	0.000622	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	4.1e-05	0.000616	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.08e-05	0.000613	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	4.07e-05	0.000611	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	4.05e-05	0.000609	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	4.05e-05	0.000609	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	4.04e-05	0.000607	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—LPA—type 2 diabetes mellitus	4.01e-05	0.000602	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HSD3B2—type 2 diabetes mellitus	4.01e-05	0.000602	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GCKR—type 2 diabetes mellitus	4.01e-05	0.000602	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—KCNJ11—type 2 diabetes mellitus	4.01e-05	0.000602	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	4e-05	0.0006	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PCK1—type 2 diabetes mellitus	3.96e-05	0.000594	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.9e-05	0.000585	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.86e-05	0.000579	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALDOB—type 2 diabetes mellitus	3.85e-05	0.000578	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.8e-05	0.000571	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.74e-05	0.000561	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HK1—type 2 diabetes mellitus	3.71e-05	0.000556	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.7e-05	0.000556	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	3.7e-05	0.000555	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.66e-05	0.00055	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	3.63e-05	0.000545	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.62e-05	0.000543	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	3.58e-05	0.000537	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—LPA—type 2 diabetes mellitus	3.58e-05	0.000537	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	3.58e-05	0.000537	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	3.58e-05	0.000537	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GLP1R—type 2 diabetes mellitus	3.58e-05	0.000537	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.44e-05	0.000517	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	3.43e-05	0.000515	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC2A2—type 2 diabetes mellitus	3.34e-05	0.000501	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.33e-05	0.0005	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MTR—type 2 diabetes mellitus	3.27e-05	0.000491	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CPT1A—type 2 diabetes mellitus	3.27e-05	0.000491	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	3.27e-05	0.000491	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.27e-05	0.00049	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.23e-05	0.000485	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	3.23e-05	0.000485	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NAMPT—type 2 diabetes mellitus	3.21e-05	0.000482	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	3.19e-05	0.000479	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.19e-05	0.000479	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GCK—type 2 diabetes mellitus	3.19e-05	0.000479	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HBA1—type 2 diabetes mellitus	3.19e-05	0.000479	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—LIPC—type 2 diabetes mellitus	3.19e-05	0.000479	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP11A1—type 2 diabetes mellitus	3.17e-05	0.000476	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	3.16e-05	0.000475	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC9A1—type 2 diabetes mellitus	3.11e-05	0.000467	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.11e-05	0.000467	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CETP—type 2 diabetes mellitus	3.07e-05	0.000462	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.06e-05	0.00046	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.02e-05	0.000453	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	2.98e-05	0.000447	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MTR—type 2 diabetes mellitus	2.92e-05	0.000438	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	2.92e-05	0.000438	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	2.92e-05	0.000438	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	2.88e-05	0.000432	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.87e-05	0.000431	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	2.86e-05	0.00043	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PSMD6—type 2 diabetes mellitus	2.86e-05	0.000429	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SNAP25—type 2 diabetes mellitus	2.86e-05	0.000429	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SREBF1—type 2 diabetes mellitus	2.86e-05	0.000429	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.84e-05	0.000427	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	2.84e-05	0.000427	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	2.84e-05	0.000427	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GCK—type 2 diabetes mellitus	2.84e-05	0.000427	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	2.83e-05	0.000424	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	2.82e-05	0.000424	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CTGF—type 2 diabetes mellitus	2.81e-05	0.000421	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HMGCR—type 2 diabetes mellitus	2.78e-05	0.000418	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	2.77e-05	0.000417	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CETP—type 2 diabetes mellitus	2.74e-05	0.000412	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.74e-05	0.000412	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ADRA2A—type 2 diabetes mellitus	2.72e-05	0.000409	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—INS—type 2 diabetes mellitus	2.7e-05	0.000406	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	2.66e-05	0.000399	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2E1—type 2 diabetes mellitus	2.61e-05	0.000393	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	2.61e-05	0.000392	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC2A1—type 2 diabetes mellitus	2.59e-05	0.000388	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1A2—type 2 diabetes mellitus	2.59e-05	0.000388	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.56e-05	0.000384	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	2.55e-05	0.000383	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	2.55e-05	0.000383	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	2.55e-05	0.000383	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP3A4—type 2 diabetes mellitus	2.52e-05	0.000379	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.51e-05	0.000377	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	2.5e-05	0.000376	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	2.48e-05	0.000373	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC2A4—type 2 diabetes mellitus	2.48e-05	0.000372	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GCG—type 2 diabetes mellitus	2.48e-05	0.000372	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.45e-05	0.000367	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	2.43e-05	0.000365	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	2.41e-05	0.000362	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	2.37e-05	0.000356	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.37e-05	0.000356	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	2.33e-05	0.00035	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	2.33e-05	0.00035	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	2.31e-05	0.000346	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	2.31e-05	0.000346	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	2.25e-05	0.000338	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.24e-05	0.000336	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GCG—type 2 diabetes mellitus	2.21e-05	0.000332	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	2.21e-05	0.000332	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GNB3—type 2 diabetes mellitus	2.14e-05	0.000321	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.14e-05	0.000321	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HMOX1—type 2 diabetes mellitus	2.13e-05	0.000319	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CAT—type 2 diabetes mellitus	2.1e-05	0.000315	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.07e-05	0.000311	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.07e-05	0.000311	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—APOB—type 2 diabetes mellitus	2.04e-05	0.000306	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	1.98e-05	0.000298	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.96e-05	0.000295	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.96e-05	0.000295	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—LPL—type 2 diabetes mellitus	1.94e-05	0.000292	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.91e-05	0.000286	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	1.91e-05	0.000286	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	1.9e-05	0.000286	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	1.9e-05	0.000285	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	1.9e-05	0.000285	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.87e-05	0.000281	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CAT—type 2 diabetes mellitus	1.87e-05	0.000281	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CD36—type 2 diabetes mellitus	1.85e-05	0.000277	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	1.82e-05	0.000274	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—APOB—type 2 diabetes mellitus	1.82e-05	0.000273	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	1.77e-05	0.000265	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	1.75e-05	0.000263	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—LPL—type 2 diabetes mellitus	1.73e-05	0.000261	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.73e-05	0.00026	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.73e-05	0.00026	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	1.72e-05	0.000258	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	1.7e-05	0.000255	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	1.69e-05	0.000254	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.67e-05	0.000251	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.67e-05	0.000251	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.67e-05	0.000251	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.67e-05	0.000251	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.67e-05	0.000251	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—AGT—type 2 diabetes mellitus	1.66e-05	0.00025	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	1.65e-05	0.000248	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	1.64e-05	0.000246	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—APOE—type 2 diabetes mellitus	1.63e-05	0.000245	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	1.63e-05	0.000244	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.62e-05	0.000243	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	1.61e-05	0.000242	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	1.56e-05	0.000235	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	1.53e-05	0.00023	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.53e-05	0.000229	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.53e-05	0.000229	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.49e-05	0.000223	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	1.48e-05	0.000223	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	1.46e-05	0.000219	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	1.45e-05	0.000218	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	1.44e-05	0.000216	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	1.42e-05	0.000213	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.42e-05	0.000213	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.42e-05	0.000213	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.42e-05	0.000213	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—INS—type 2 diabetes mellitus	1.39e-05	0.000209	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.36e-05	0.000204	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.36e-05	0.000204	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.31e-05	0.000197	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.31e-05	0.000197	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.29e-05	0.000193	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALB—type 2 diabetes mellitus	1.28e-05	0.000192	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	1.27e-05	0.00019	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.27e-05	0.00019	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.27e-05	0.00019	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.27e-05	0.00019	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—INS—type 2 diabetes mellitus	1.24e-05	0.000187	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-05	0.000183	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-05	0.000183	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.19e-05	0.000179	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	1.14e-05	0.000171	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-05	0.000168	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.11e-05	0.000167	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000164	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	1.09e-05	0.000164	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.08e-05	0.000162	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.08e-05	0.000162	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.08e-05	0.000162	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.08e-05	0.000162	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.03e-05	0.000155	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	9.96e-06	0.00015	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.59e-06	0.000144	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.95e-06	0.000134	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	8.77e-06	0.000132	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	8.77e-06	0.000132	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.6e-06	0.000129	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.55e-06	0.000128	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.55e-06	0.000128	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.55e-06	0.000128	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8.49e-06	0.000128	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.34e-06	0.000125	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	8.25e-06	0.000124	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.67e-06	0.000115	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.67e-06	0.000115	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.67e-06	0.000115	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.52e-06	0.000113	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.46e-06	0.000112	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.3e-06	0.00011	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.01e-06	0.000105	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.93e-06	0.000104	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.93e-06	0.000104	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.65e-06	9.98e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.65e-06	9.98e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.73e-06	8.6e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.73e-06	8.6e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.7e-06	8.56e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.63e-06	8.45e-05	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	5.61e-06	8.43e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.46e-06	8.2e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.31e-06	7.98e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.22e-06	7.83e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.11e-06	7.67e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.09e-06	7.64e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	5.01e-06	7.52e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.96e-06	7.44e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.89e-06	7.35e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.7e-06	7.05e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.61e-06	6.92e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.46e-06	6.7e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.39e-06	6.59e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.37e-06	6.56e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.32e-06	6.49e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.81e-06	5.72e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.73e-06	5.61e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.42e-06	5.14e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.28e-06	4.92e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.28e-06	4.92e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3e-06	4.5e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.51e-06	2.26e-05	CbGpPWpGaD
